Vaccine To Prevent Kidney Cancer Recurrence Not Shown To Be Effective

July 05th, 2008 | Category: Cancer

A randomized trial that studied the impact of the new vitespen vaccine, administered after surgery for kidney cancer, losed out to demonstrate an increase in recurrence-free survival (RFS). More research is needed, according to the

study authors, in order to know whether the vaccine can increase RFS whether given to patients during the early stages of the disease.

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Cancerbackup Welcomes Cervical Cancer Vaccine, UK
  • Interventional Cryoablation Stops Cancer Cold Curative Option For Patients With Small Localized Kidney Tumors
  • Vaccine Induced Inflammation Linked To Epidemic Of Type 2 Diabetes And Metabolic Syndrome
  • Researchers Train The Immune System To Deliver Virus That Destroys Cancer In Lab Models
  • Ovarian Cancer Stem Cells Identified, Characterized And Cloned, Leading To More Effective Treatment

    • No comments yet. Be the first.

    Leave a reply